Medivir AB (publ)
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-32.59-30.52-154.1824.22
Price/Sales ratio
14.5573.394.231.53
Earnings per Share (EPS)
SEK-1.27SEK-1.36SEK-0.27SEK1.72

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
14.403.3030.8511.36-3.58-2.07-2.97-4.91-9.33-6.18N/A-3.58
Price/Sales ratio
0.512.113.5234.5535.2630.4442.0414.4523.07125.17N/A30.44
Price/Book Value ratio
0.271.881.591.852.512.361.981.422.092.86N/A2.36
Price/Cash Flow ratio
5.353.687.53-17.63-3.60-2.27-2.47-3.47-12.08-5.41N/A-3.60
Price/Free Cash Flow ratio
5.843.768.06-11.14-3.47-2.23-2.45-3.31-12.08-5.39N/A-3.47
Price/Earnings Growth ratio
-0.13-0.00-0.330.030.010.190.040.070.68-0.18N/A0.19
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
83.91%90.15%83.38%82.85%100%100%-943.82%-279.49%-186.93%-1467.10%N/A100%
Operating Profit Margin
7.89%67.27%17.44%-335.73%-990.29%-1471.02%-1444.05%-307.57%-243.23%-1981.71%N/A-990.29%
Pretax Profit Margin
6.19%67.49%15.49%-329.65%-981.81%-1468.69%-1413.73%-305.56%-245.04%-2013.72%N/A-981.81%
Net Profit Margin
3.58%64.10%11.41%304.00%-983.15%-1468.02%-1414.94%-294.28%-247.18%-2024.06%N/A-983.15%
Effective Tax Rate
42.04%5.02%26.34%3.86%-0.13%0.04%-0.08%3.69%-0.87%-0.51%N/A-0.13%
Return on Assets
1.60%51.86%4.64%14.72%-58.46%-83.53%-42.06%-21.43%-18.79%-38.09%N/A-58.46%
Return On Equity
1.87%57.13%5.17%16.32%-70.07%-113.88%-66.92%-28.92%-22.45%-46.27%N/A-70.07%
Return on Capital Employed
3.94%59.95%7.91%-18.02%-70.58%-108.89%-52.82%-27.36%-21.12%-42.36%N/A-70.58%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
4.228.517.079.474.783.212.772.275.414.39N/A3.21
Cash ratio
3.900.421.311.020.570.480.620.400.350.23N/A0.48
Days of Sales Outstanding
26.52N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
121.9649.5162.449.88N/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
148.4849.5162.449.88N/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
145.8385.48123.751.30KN/AN/A49.3146.9451.4919.88N/AN/A
Cash Conversion Cycle
2.64-35.96-61.31-1.29KN/AN/A-49.31-46.94-51.49-19.88N/AN/A
Debt Ratios
Debt Ratio
0.040.01N/AN/AN/AN/A0.140.080.040.06N/AN/A
Debt Equity Ratio
0.040.02N/AN/AN/AN/A0.230.110.040.08N/AN/A
Long-term Debt to Capitalization
0.04N/AN/AN/AN/AN/A0.160.090.040.06N/AN/A
Total Debt to Capitalization
0.040.01N/AN/AN/AN/A0.190.100.040.07N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
1.0725.35N/AN/AN/AN/A-3.37-3.52-3.47-6.56N/AN/A
Company Equity Multiplier
1.161.101.111.101.191.361.591.341.191.21N/A1.36
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.090.570.46-1.95-9.78-13.35-16.99-4.16-1.90-23.09N/A-9.78
Free Cash Flow / Operating Cash Flow Ratio
0.910.980.931.581.031.021.001.0411.00N/A1.02
Cash Flow Coverage Ratio
1.0725.35N/AN/AN/AN/A-3.37-3.52-3.47-6.56N/AN/A
Short Term Coverage Ratio
N/A25.35N/AN/AN/AN/A-22.03-36.28-46.23-48.18N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A